Your browser doesn't support javascript.
loading
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1.
Tan, Wenliang; Lin, Zhirong; Chen, Xianqing; Li, Wenxin; Zhu, Sicong; Wei, Yingcheng; Huo, Liyun; Chen, Yajin; Shang, Changzhen.
Afiliação
  • Tan W; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Lin Z; Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Li W; Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhu S; Department of Hepatobiliary Surgery, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Wei Y; Department of Cardiology, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Huo L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Chen Y; Department of Surgical Intensive Care Unit, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Shang C; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Ann Transl Med ; 9(1): 38, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33553331

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article